Niquitin Minilozenge Citrus (Nicotine)

Niquitin Minilozenge Citrus, a nicotine replacement therapy, is used to support smoking cessation by addressing nicotine dependence.

• Smoking cessation: assists adult smokers in quitting by alleviating nicotine withdrawal symptoms.
• Reduction of nicotine cravings: provides controlled nicotine delivery to lessen the urge to smoke.
• Adjunct to behavioral counseling: used together with counseling programs to improve quit rates.

• Nicotine acts as an agonist at nicotinic acetylcholine receptors in the central nervous system, particularly the α4β2 subtype. By stimulating these receptors, it partially mimics the pharmacologic effects of tobacco‑derived nicotine, reducing the intensity of withdrawal and craving while allowing gradual tapering of nicotine exposure.

Niquitin Minilozenge Citrus may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Mouth irritation: mild soreness or tingling in the oral cavity.
• Nausea: feeling of queasiness after lozenge use.
• Hiccups: brief episodes of involuntary diaphragm contraction.
• Increased salivation: excess saliva production.

Serious or Rare Side Effects

• Severe allergic reaction: rash, swelling, or difficulty breathing requiring immediate medical attention.
• Chest pain or palpitations: may indicate cardiovascular stress and should be evaluated promptly.
• Persistent dizziness: prolonged vertigo that does not resolve.

When using Niquitin Minilozenge Citrus, certain precautions should be observed to ensure safe and effective use.

• Assess nicotine dependence: determine appropriate lozenge strength and duration with a healthcare professional.
• Avoid use in non‑smokers: nicotine replacement is intended for individuals actively trying to quit smoking.
• Monitor cardiovascular status: patients with heart disease should use under medical supervision.
• Limit concurrent nicotine sources: do not combine with other nicotine products to prevent excess exposure.
• Pregnancy and lactation: discuss risks with a clinician as safety data are limited.
• Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Nicotine may interact with certain medicines, altering their effects or increasing adverse reactions.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): concurrent use can heighten hypertensive risk.
• Insulin or oral hypoglycemics: nicotine may affect blood glucose control, requiring dose adjustment.
• Warfarin: nicotine may enhance anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: nicotine can reduce their efficacy in controlling heart rate.
• Theophylline: nicotine may increase plasma concentrations, necessitating monitoring.
• Antidepressants (SSRIs): nicotine may alter metabolism, requiring observation for side effects.